03016nam 2200565 a 450 991043783080332120200520144314.01-283-84897-X1-4614-4732-110.1007/978-1-4614-4732-0(CKB)2670000000278640(EBL)1030812(OCoLC)820362341(SSID)ssj0000789991(PQKBManifestationID)11430979(PQKBTitleCode)TC0000789991(PQKBWorkID)10737083(PQKB)10495643(DE-He213)978-1-4614-4732-0(MiAaPQ)EBC1030812(PPN)168301059(EXLCZ)99267000000027864020120924d2013 uy 0engur|n|---|||||txtccrCancer immunotherapy paradigms, practice and promise /Tyler Curiel, editorNew York Springer20131 online resource (485 p.)Description based upon print version of record.1-4614-4731-3 Includes bibliographical references and index.pt. I. Overview -- pt. II. Passive strategies to boost antitumor immunity -- pt. III. Active strategies to boost antitumor immunity -- pt. IV. Additional strategies and considerations.This volume is a comprehensive discussion of the major factors affecting tumor immunology and a discussion of all major anti-cancer immunotherapeutic agents approved by the Food and Drug Administration of the United States and by European agencies. Many promising but unapproved agents in clinical trials are also discussed, as are key pre-clinical developments. The major challenges and intellectual issues facing investigators developing novel immunotherapeutics are discussed in detail as are conceptual developments influencing current and future treatment strategies. Each chapter begins by defining all relevant key terms and concepts and provides pertinent background information so that the text will be accessible to newcomers to the field as well as to the expert. This text book should provide an excellent reference resource for investigators in tumor immunology, life sciences students, drug developers designing novel anti-cancer immunotherapeutics, and to other individuals with some scientific training wishing to gain a better understanding of the field of tumor immunotherapy. Although the field is evolving rapidly, we have taken pains to ensure that information was as up to date as possible as the text went to press.CancerImmunological aspectsImmunotherapyCancerImmunological aspects.Immunotherapy.616.99616.994061Curiel Tyler1061617MiAaPQMiAaPQMiAaPQBOOK9910437830803321Cancer immunotherapy2519370UNINA01052nam0 22002531i 450 UON0003134820231205102102.65920020107d1907 |0itac50 bagerTUODE|||| |||||Deutsch-Turkisches Konversationbuch (Methode Gaspey-Otto-SauerJames ConnorHeidelbergGroos1924 viii,285 p. ; 15 cmLingua turco ottomanaGrammaticheUONC006404FIDEHeidelbergUONL000174OTT II BIMPERO OTTOMANO - LINGUISTICA - GRAMMATICHEACONNORJamesUONV020826632635Julius GroosUONV254375650ITSOL20241115RICASIBA - SISTEMA BIBLIOTECARIO DI ATENEOUONSIUON00031348SIBA - SISTEMA BIBLIOTECARIO DI ATENEOSI OTT II B 023 SI SA 19402 7 023 Deutsch-Turkisches Konversationbuch (Methode Gaspey-Otto-Sauer1189487UNIOR